Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-05-23 4:06 pm Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | INTRACOASTAL CAPITAL LLC | 110,727 4.990% | 110,727 (New Position) | View |
2024-01-02 10:11 am Sale | 13G | Virpax Pharmaceuticals Inc. VRPX | SABBY MANAGEMENT LLC | 0 0.000% | -988,165 (Position Closed) | View |
2023-02-14 4:05 pm Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | Mack Anthony P. | 3,080,566 26.100% | 112,641 (+3.80%) | View |
2023-01-26 4:05 pm Sale | 13G | Virpax Pharmaceuticals Inc. VRPX | Kepos Capital LP | 0 0.000% | -750,000 (Position Closed) | View |
2023-01-10 1:36 pm Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | SABBY MANAGEMENT LLC | 988,165 11.000% | 111,331 (+12.70%) | View |
2022-02-14 4:34 pm Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | Mack Anthony P. | 2,967,925 25.200% | 2,967,925 (New Position) | View |
2022-02-14 3:23 pm Sale | 13G | Virpax Pharmaceuticals Inc. VRPX | CVI Investments Inc. | 0 0.000% | -1,000,000 (Position Closed) | View |
2022-02-04 08:18 am Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | Kepos Capital LP | 750,000 6.400% | 750,000 (New Position) | View |
2022-01-04 11:31 am Sale | 13G | Virpax Pharmaceuticals Inc. VRPX | SABBY MANAGEMENT LLC | 876,834 11.000% | -123,166 (-12.32%) | View |
2021-09-23 07:29 am Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | SABBY MANAGEMENT LLC | 1,000,000 11.000% | 1,000,000 (New Position) | View |
2021-09-21 4:33 pm Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | Altium Capital Management LP | 1,000,000 8.500% | 1,000,000 (New Position) | View |
2021-09-20 10:32 am Purchase | 13G | Virpax Pharmaceuticals Inc. VRPX | CVI Investments Inc. | 1,000,000 8.500% | 1,000,000 (New Position) | View |